Discounted Cash Flow (DCF) Analysis Levered
CareDx, Inc (CDNA)
$7.93
-0.46 (-5.48%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 76.57 | 127.07 | 192.19 | 296.40 | 321.79 | 466.59 | 676.55 | 980.98 | 1,422.40 | 2,062.45 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | -4.01 | -2.77 | 33.43 | -19.29 | -25.24 | -4.08 | -5.91 | -8.58 | -12.43 | -18.03 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -7.24 | -3.35 | -10.36 | -20.26 | -24.33 | -29.74 | -43.13 | -62.54 | -90.68 | -131.48 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | -11.24 | -6.12 | 23.07 | -39.55 | -49.57 | -33.82 | -49.04 | -71.11 | -103.11 | -149.51 |
Weighted Average Cost Of Capital
Share price | $ 7.93 |
---|---|
Beta | 1.032 |
Diluted Shares Outstanding | 53.32 |
Cost of Debt | |
Tax Rate | -0.50 |
After-tax Cost of Debt | 9.65% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.612 |
Total Debt | 39 |
Total Equity | 422.84 |
Total Capital | 461.84 |
Debt Weighting | 8.44 |
Equity Weighting | 91.56 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 76.57 | 127.07 | 192.19 | 296.40 | 321.79 | 466.59 | 676.55 | 980.98 | 1,422.40 | 2,062.45 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | -4.01 | -2.77 | 33.43 | -19.29 | -25.24 | -4.08 | -5.91 | -8.58 | -12.43 | -18.03 |
Capital Expenditure | -7.24 | -3.35 | -10.36 | -20.26 | -24.33 | -29.74 | -43.13 | -62.54 | -90.68 | -131.48 |
Free Cash Flow | -11.24 | -6.12 | 23.07 | -39.55 | -49.57 | -33.82 | -49.04 | -71.11 | -103.11 | -149.51 |
WACC | ||||||||||
PV LFCF | -28.63 | -38.19 | -50.94 | -67.94 | -90.63 | |||||
SUM PV LFCF | -300.37 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 8.70 |
Free cash flow (t + 1) | -152.50 |
Terminal Value | -2,276.10 |
Present Value of Terminal Value | -1,499.83 |
Intrinsic Value
Enterprise Value | -1,800.20 |
---|---|
Net Debt | -50.92 |
Equity Value | -1,749.28 |
Shares Outstanding | 53.32 |
Equity Value Per Share | -32.81 |